七、小结与展望

更新于 2026年11月19日 版权声明
七、小结与展望

VP也可称为脑卒中后PD,是由多发性LI、皮质下白质脑病等脑血管病所引起的继发性PS,常于多次卒中后逐渐出现或急性脑卒中后突然发生。临床表现多以双侧对称、下肢为主的姿势步态异常为突出症状,静止性震颤少发,常伴有假性延髓麻痹、锥体束征等症状。目前尚无统一的诊断标准及治疗方案,MRI 等影像学检查有助于VP 的诊断,治疗上仍以足量、足疗程的左旋多巴为主。

VP的发病机制复杂,影响因素众多,一些治疗手段尚无定论,仍需要进一步研究。但是,及时对其中一些可干预的因素(如监控血压、血糖,生活方式等)进行早期干预,有可能延缓疾病进展,提高患者的生活质量。另外,还应继续加强VP病理机制等方面的研究,尽早制订统一的VP诊断标准,不断探索VP 的治疗方法及筛选新的有效治疗药物,从而制订出可行性强、效果明确的早期干预方案。

参考文献

[1]Brissaud E.Lecons Sur maladies nerveuses[J].Paris Massion,1895,469.

[2]Critchley M.Arteriosclerotic parkinsonism[J].Brain,1929,52:23-83.

[3]Caslake R,Taylor K,Scott N,et al.Age,and gender specific incidence of vascular parkinsonism,progressive supranuclear palsy,and parkinsonian type multiple system atrophy in North East Scotland:the PINE study[J].Parkinsonism Relat Disord,2014,20(8):834-839.

[4]Thanvi B,Lo N,Robinson T.Vascular parkinsom-an important cause of parkinsonism in older people[J].Age Ageing,2005,34(2):114-119.

[5]Foltynie T,Barker R,Brayne C.Vascular parkinsonism:a review of the precision and frequency of the diagnosis[J].Neuroepidemiology,2002,21(1):1-7.

[7]Honczarenko K,Budzianowska A.Clinical correlation of vascular parkinsonism[J].Neurol Neurochir Pol,2003,37(5):155-164.

[8]Benito-Leon J,Berinejo-Pareja F,Morales Gonzalez JM,et al.Incidence of Parkinson's disease and parkinsonism in three elderly populations of central Spain[J].Neurology,2004,62(5):734-741.

[9]Huang Z,Jacewicz M,Pfeiffer RF.Anticardiolipin antibody in vascular parkinsonism[J].Mov Disord,2002,17(5):992-997.

[10]Jellinger KA.The pathology of Parkinson's disease[J].Adv Neurol,2001,86:55-72.

[11]Handley A,Medcalf P,Hellier K,et al.Movement disorders after stroke[J].Age Ageing,2009,38(3):260-266.

[12]de Laat KF,Tuladhar AM,van Norden AG,et al.Loss of white matter integrity is associated with gait disorders in cerebral small cessals disease[J].Age Ageing,2009,38(3):260-266.

[13]Louis ED,Luchsinger JA.History of vascular diseasa and mild parkinsonian signs in community-dwelling elderly individuals[J].Arch Neurol,2006,63(5):717-722.

[14]Reitz C,Trenkwalder C,Kretzschmar K,et al.Relation of cerebral small vessel disease and brain atrophy to mild Parkinsonism in the elderly[J].Mov Disord,2006,21(11):1914-1919.

[15]de Laat KF,van Norden AG,van Oudheusden LJ,et al.Diffusion tensor imaging and mild parkinsonian in cerebral small vessel disease[J].Neurobiol Aging,2012,33(9):2106-2112.

[16]赵德强.血管性帕金森综合征与帕金森病临床特点及影像学的对比研究[J].第一军医大学学报,2005,25(7):868-870.

[17]Sibon I,Fenelon G,Quinn NP,et al.Vascular parkinsionism[J].J Neurol,2004,251(5):513-524.

[18]Demirkiran M,Bozdemir H,Sarica Y.Vascular parkinsonism:a distinct,heterogeneous clinical entity[J].Acta Neurol Scand,2001,104(2):63-67.

[19]Rektor I,Rektorova I,Kubova D.Vascular parkinsonism-an update[J].J Neurol Sci,2006,248(1/2):185-191.

[21]Fujimoto K.Vascular parkinsonism[J].J Neurol,2006,253(1):16-21.(https://www.daowen.com)

[23]Gupta D,Kuruvilla A.Vascular parkinsonism:what makes it different?[J].Postgrad Med J,2011,87(1034):829-836.

[24]Korczyn AD.Vascular parkinsonism—characteristics,pathogenesis and treatment[J].Nat Rev Neurol,2015,11(6):319-326.

[25]Factor SA.The clinical spectrum of freezing of gait in atypical parkinsonism[J].Mov Disord,2008,3(Suppl 2):S431-S438.

[26]Okuda B,Kawabata K,Tachibana H,et al.Primitive reflexes distinguish vascular parkinsonism from Parkinson's disease[J].Clin Neurol Neurosurg,2008,110(6):562-565.

[27]Santangelo G,Vitale C,Trojano L,et al.Differential neuropsychological profiles in Parkinsonian patients with or without vascular lesions[J].Mov Disord,2010,25(1):50-56.

[28]Benítez-Rivero S,Lama MJ,Huertas-Fernandez I,et al.Clinical features and neuropsychological profile in vascular parkinsonism[J].J Neurol Sci,2014,345(1/2):193-197.

[29]刘静.血管性帕金森综合征的临床特点及影像学分析[J].现代实用医学,2014,26(7):824-825.

[30]Winikates J,Jankovic J.Clinical correlates of vascular parkinsonism[J].Arch Neurol,1999,56(1):98-102.

[31]Rektor I,Rektorova I,Kubova D.Vascular parkinsonism-an update[J].J Neurol Sci,2006,248(1/2):185-191.

[32]Yamanouchi H,Nagura H.Neurological sign and frontal white matter lesion in vascular parkinsonism[J].Stroke,1997,28(5):965-969.

[33]Zijlmans JC,Daniel SE,Hughes AJ,et al.Clinicopathologicalinvestigation of vascular parkinsonism,including cilnical criteria for diagnosis[J].Mov Disord,2004,19(6):630-640.

[34]王国平,江艳,李淮玉,等.血管性帕金森综合征患者的临床与磁共振成像研究[J].中华老年心脑血管病杂志,2008,10(2):122-124.

[35]Sitburana O,Ondo WG.Brain magnetic resonance imaging(MRI)in parkinsonian disorders[J].Parkinsonism Relat Disord,2009,15(3):165-174.

[36]Marshall V,Grossetc D.Role of dopamine transporter imaging in routine clinical practice[J].Mov Disord,2003,18(12):1415-1423.

[37]Zijlmans J,Evans A,Fontes F,et al.FPCIT SPECT study in vascular parkinsonism and Parkinson's disease[J].Mov Disord,2007,22(9):1278-1285.

[38]Huang WS,Lee MS,Lin JC,et al.Usefulness of brain 99Tcm-TRODAT-1 SPECT for the evaluation of Parkinson'S disease[J].Eur J Nucl Med Mol Imaging,2004,31(2):155-161.

[39]Constantinescu R,Richard I,Kurlan R.Levodopa responsiveness in disorders with parkinsonism:a review of the literature[J].Mov Disord,2007,22(15):2141-2148.

[40]Zijlmans JC,Katzenschlager R,Daniel SE,et al.The L-dopa response in vascular parkinsonism[J].J Neurol Neurosurg Psychiatry,2004,75(4):545-547.

[41]高桂秀.神经节苷脂联合普拉克索治疗血管性帕金森综合征效果分析[J].中国实用神经疾病杂志,2015,18(7):107-108.

[42]林荃.神经节苷脂治疗血管性帕金森综合征的临床分析[J].临床医学,2014,27(11):62-63.

(刘运林)

✍AI写作